RYTM - Company ID 0001649904
The table below shows RHYTHM PHARMACEUTICALS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $54.30M | $89.14M | $60.08M | $127.68M | $59.25M | $100.85M |
| Short-term investments | $334.65M | $231.43M | $215.76M | $205.61M | $235.61M | $71.94M |
| Receivables | $26.08M | $18.51M | $14.87M | $6.22M | $1.02M | - |
| Inventory | $25.75M | $18.74M | $8.62M | $2.92M | $111.00K | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $466.92M |
| $374.20M |
| $308.27M |
| $354.24M |
| $308.39M |
| $181.67M |
| Property, plant & equipment | $1.10M | $632.00K | $1.34M | $2.20M | $2.81M | $3.19M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $480.20M | $392.27M | $332.75M | $382.48M | $329.52M | $187.07M |
| Accounts payable | $13.95M | $12.33M | $4.88M | $4.80M | $5.74M | $4.90M |
| Total current liabilities | $105.94M | $115.52M | $55.20M | $39.81M | $43.43M | $17.99M |
| Long-term debt | $100.89M | $108.27M | - | - | - | - |
| Total liabilities | $210.17M | $227.72M | $162.99M | $118.22M | $45.37M | $20.55M |
| Retained earnings | -$1.35B | -$1.16B | -$894.74M | -$710.06M | -$528.94M | -$459.33M |
| Total equity | $139.07M | $21.73M | $169.76M | $264.26M | $284.15M | $166.53M |